Epidemiological characteristics and prognostic risk factors of pulmonary blastoma based on the 2021 WHO classification

Abstract Pulmonary blastoma (PB) is a rare and aggressive lung malignancy. Prior studies were confounded by inconsistent histological classifications, particularly before the 2021 World Health Organization (WHO) reclassification. This study aimed to characterize PB’s epidemiological features and pro...

Full description

Saved in:
Bibliographic Details
Main Authors: Lu Yang, Lei Yu, Shimin Tang, Ji Ma, Qiang Zhou, Li Liu, Yong Li, Na Li
Format: Article
Language:English
Published: Nature Portfolio 2025-07-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-08571-5
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849769358948040704
author Lu Yang
Lei Yu
Shimin Tang
Ji Ma
Qiang Zhou
Li Liu
Yong Li
Na Li
author_facet Lu Yang
Lei Yu
Shimin Tang
Ji Ma
Qiang Zhou
Li Liu
Yong Li
Na Li
author_sort Lu Yang
collection DOAJ
description Abstract Pulmonary blastoma (PB) is a rare and aggressive lung malignancy. Prior studies were confounded by inconsistent histological classifications, particularly before the 2021 World Health Organization (WHO) reclassification. This study aimed to characterize PB’s epidemiological features and prognostic factors under the updated 2021 WHO criteria. Data on patients diagnosed with PB from the The Surveillance, Epidemiology, and End Results (SEER) database between 2000 and 2020 were collected. Kaplan-Meier curves were used to evaluate overall survival (OS), and univariate/multivariate Cox regression analysis was employed to identify independent factors affecting prognosis. PB affected females more frequently (61.5%) and occurred across all ages without a clear peak. The median tumor size was 77.83 mm, with upper/lower lung lobes being common sites. Surgical resection was performed in 73.8% of patients. The 1-, 3-, and 5-year OS rates were 70.3%, 57.2%, and 51.9%, respectively. Multivariate analysis revealed age, histological grade, and surgical status as independent prognostic factors. This study provides the first comprehensive analysis of PB under the 2021 WHO classification, demonstrating improved survival outcomes compared to historical reports. Age, histological grade, and surgical intervention are critical prognostic determinants. These findings underscore the importance of accurate histological classification and surgical resection in optimizing PB management.
format Article
id doaj-art-6a4452ea68754d36a3e2c40a0aaff70c
institution DOAJ
issn 2045-2322
language English
publishDate 2025-07-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-6a4452ea68754d36a3e2c40a0aaff70c2025-08-20T03:03:25ZengNature PortfolioScientific Reports2045-23222025-07-011511710.1038/s41598-025-08571-5Epidemiological characteristics and prognostic risk factors of pulmonary blastoma based on the 2021 WHO classificationLu Yang0Lei Yu1Shimin Tang2Ji Ma3Qiang Zhou4Li Liu5Yong Li6Na Li7Suining Central HospitalSuining Central HospitalSuining Central HospitalSuining Central HospitalSuining Central HospitalSuining Central HospitalSuining Central HospitalSuining Central HospitalAbstract Pulmonary blastoma (PB) is a rare and aggressive lung malignancy. Prior studies were confounded by inconsistent histological classifications, particularly before the 2021 World Health Organization (WHO) reclassification. This study aimed to characterize PB’s epidemiological features and prognostic factors under the updated 2021 WHO criteria. Data on patients diagnosed with PB from the The Surveillance, Epidemiology, and End Results (SEER) database between 2000 and 2020 were collected. Kaplan-Meier curves were used to evaluate overall survival (OS), and univariate/multivariate Cox regression analysis was employed to identify independent factors affecting prognosis. PB affected females more frequently (61.5%) and occurred across all ages without a clear peak. The median tumor size was 77.83 mm, with upper/lower lung lobes being common sites. Surgical resection was performed in 73.8% of patients. The 1-, 3-, and 5-year OS rates were 70.3%, 57.2%, and 51.9%, respectively. Multivariate analysis revealed age, histological grade, and surgical status as independent prognostic factors. This study provides the first comprehensive analysis of PB under the 2021 WHO classification, demonstrating improved survival outcomes compared to historical reports. Age, histological grade, and surgical intervention are critical prognostic determinants. These findings underscore the importance of accurate histological classification and surgical resection in optimizing PB management.https://doi.org/10.1038/s41598-025-08571-5Pulmonary BlastomaEpidemiological characteristicsRisk factorsRare lung malignancy
spellingShingle Lu Yang
Lei Yu
Shimin Tang
Ji Ma
Qiang Zhou
Li Liu
Yong Li
Na Li
Epidemiological characteristics and prognostic risk factors of pulmonary blastoma based on the 2021 WHO classification
Scientific Reports
Pulmonary Blastoma
Epidemiological characteristics
Risk factors
Rare lung malignancy
title Epidemiological characteristics and prognostic risk factors of pulmonary blastoma based on the 2021 WHO classification
title_full Epidemiological characteristics and prognostic risk factors of pulmonary blastoma based on the 2021 WHO classification
title_fullStr Epidemiological characteristics and prognostic risk factors of pulmonary blastoma based on the 2021 WHO classification
title_full_unstemmed Epidemiological characteristics and prognostic risk factors of pulmonary blastoma based on the 2021 WHO classification
title_short Epidemiological characteristics and prognostic risk factors of pulmonary blastoma based on the 2021 WHO classification
title_sort epidemiological characteristics and prognostic risk factors of pulmonary blastoma based on the 2021 who classification
topic Pulmonary Blastoma
Epidemiological characteristics
Risk factors
Rare lung malignancy
url https://doi.org/10.1038/s41598-025-08571-5
work_keys_str_mv AT luyang epidemiologicalcharacteristicsandprognosticriskfactorsofpulmonaryblastomabasedonthe2021whoclassification
AT leiyu epidemiologicalcharacteristicsandprognosticriskfactorsofpulmonaryblastomabasedonthe2021whoclassification
AT shimintang epidemiologicalcharacteristicsandprognosticriskfactorsofpulmonaryblastomabasedonthe2021whoclassification
AT jima epidemiologicalcharacteristicsandprognosticriskfactorsofpulmonaryblastomabasedonthe2021whoclassification
AT qiangzhou epidemiologicalcharacteristicsandprognosticriskfactorsofpulmonaryblastomabasedonthe2021whoclassification
AT liliu epidemiologicalcharacteristicsandprognosticriskfactorsofpulmonaryblastomabasedonthe2021whoclassification
AT yongli epidemiologicalcharacteristicsandprognosticriskfactorsofpulmonaryblastomabasedonthe2021whoclassification
AT nali epidemiologicalcharacteristicsandprognosticriskfactorsofpulmonaryblastomabasedonthe2021whoclassification